Literature DB >> 7437248

Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers.

M Ehrenfeld, M Levy, M Bar Eli, R Gallily, M Eliakim.   

Abstract

1 The effect of colchicine on polymorphonuclear leucocyte chemotaxis was assessed in eight healthy volunteers. Four of them received 1.0 mg colchicine and the other four received placebo daily for 8 successive days. 2 Chemotaxis decreased significantly within 24 h of the ingestion of colchicine; the values remained low throughout the 8 days of treatment and returned to normal within 48 h of cessation of medication. 3 There were no significant changes in the placebo treated subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437248      PMCID: PMC1430072          DOI: 10.1111/j.1365-2125.1980.tb01759.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Leucocyte locomotion and its inhibition by antimitotic drugs.

Authors:  W S Ramsey; A Harris
Journal:  Exp Cell Res       Date:  1973-12       Impact factor: 3.905

2.  Interaction of drugs with microtubule proteins.

Authors:  L Wilson; J R Bamburg; S B Mizel; L M Grisham; K M Creswell
Journal:  Fed Proc       Date:  1974-02

3.  Plasma levels of colchicine after oral administration of a single dose.

Authors:  S L Wallace; N H Ertel
Journal:  Metabolism       Date:  1973-05       Impact factor: 8.694

4.  Colchicine plasma levels. Implications as to pharmacology and mechanism of action.

Authors:  S L Wallace; B Omokoku; N H Ertel
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

5.  Pathogenesis and treatment of the acute attack of gout.

Authors:  D J McCarty
Journal:  Clin Orthop Relat Res       Date:  1970       Impact factor: 4.176

6.  Appearance of chemotactic activity following intra-articular injection of monosodium urate crystals: effect of colchicine.

Authors:  P Phelps
Journal:  J Lab Clin Med       Date:  1970-10

7.  Crystal-induced arthritis.

Authors:  P Phelps; D J McCarty
Journal:  Postgrad Med       Date:  1969-01       Impact factor: 3.840

8.  Colchicine inhibition of chemotaxis.

Authors:  J E Caner
Journal:  Arthritis Rheum       Date:  1965-10

9.  The action of colchicine in acute gout.

Authors:  S E Malawista
Journal:  Arthritis Rheum       Date:  1965-10

10.  Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine.

Authors:  S E Malawista; K G Bensch
Journal:  Science       Date:  1967-04-28       Impact factor: 47.728

View more
  11 in total

1.  Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line.

Authors:  Y A Mekori; Y Chowers; I Ducker; A Klajman
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  The effect of an oral therapeutic single-dose of griseofulvin on polymorphonuclear leukocyte migration in a casein gradient.

Authors:  U Bandmann; O Bäck; B Norberg
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 3.  Update on colchicine and its mechanism of action.

Authors:  Yair Molad
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

4.  Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine.

Authors:  D Ilfeld; S Weil; O Kuperman
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.

Authors:  C J Roberge; M Gaudry; R de Médicis; A Lussier; P E Poubelle; P H Naccache
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis.

Authors:  M Matucci-Cerinic; L Fattorini; G Gerini; A Lombardi; A Pignone; N Petrini; T Lotti
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules.

Authors:  H Asako; P Kubes; B A Baethge; R E Wolf; D N Granger
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

8.  Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease.

Authors:  Nevin Karakus; Serbulent Yigit; Goknur Kalkan; Aydin Rustemoglu; Ahmet Inanir; Ulker Gul; Gunseli Sefika Pancar; Songul Akkanet; Omer Ates
Journal:  Mol Vis       Date:  2012-06-22       Impact factor: 2.367

9.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19

10.  Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study.

Authors:  Gita Faghihi; Azam Elahipoor; Fariba Iraji; Shadi Behfar; Bahareh Abtahi-Naeini
Journal:  Adv Med       Date:  2016-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.